Varaico: Literature-Extracted Genetic Variants

Gene:AFG3L2
Variant:p.M666V
Back to variants list

AFG3L2

NM_006796.3:p.M666V

Associated Papers

LONP-1 deficiency causes dysregulated protein synthesis within mitochondria that is restored by mitoribosomal mutations.

Ali L et al.

Biorxiv : the Preprint Server for Biology, 2026

Clinical and genetic landscape of optic atrophy in 826 families: insights from 50 nuclear genes.

Zheng Y et al.

Brain : a Journal of Neurology, 2025

39423307 (PubMed )
Supplement: awae324_supplementary_data.zip › brain-2024-01629-File014.pdf

Studying Rare Movement Disorders: From Whole-Exome Sequencing to New Diagnostic and Therapeutic Approaches in a Modern Genetic Clinic.

Marsili L et al.

Biomedicines, 2024

39767580 (PubMed )
Supplement: biomedicines-12-02673-s001.zip › Supplementary_Table_S1.pdf

Multifaceted Roles of AFG3L2, a Mitochondrial ATPase in Relation to Neurological Disorders.

Ghosh Dastidar R et al.

Molecular Neurobiology, 2024

Clinical Features and Genetic Spectrum of Patients With Clinically Suspected Hereditary Progressive Spastic Paraplegia.

Shi Y et al.

Frontiers in Neurology, 2022

ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.

Caporali L et al.

Annals of Neurology, 2020

Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation.

Szpisjak L et al.

Cerebellum (london, England), 2017

Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia.

Nibbeling EAR et al.

Brain : a Journal of Neurology, 2017

Sources of discordance among germ-line variant classifications in ClinVar.

Yang S et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017

28569743 (PubMed )
Supplement: gim201760x7.xlsx › table_all_ExAC_consensus_Oct201

A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability.

Charif M et al.

Frontiers in Genetics, 2015

A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28.

Löbbe AM et al.

Journal of Molecular Neuroscience : Mn, 2014

Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathways.

Mancini C et al.

Bmc Medical Genomics, 2013

Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.

Cagnoli C et al.

Human Mutation, 2010

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."